Portage Biotech Inc.
PRTG
$5.42
-$0.54-9.06%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 0.00% | -37.90% | 17.87% | 93.35% | 36.79% |
Total Depreciation and Amortization | 0.00% | 42.86% | -12.50% | -38.46% | -13.33% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 0.00% | 566.48% | 90.95% | -104.56% | -38.94% |
Change in Net Operating Assets | 0.00% | 387.07% | -111.98% | 409.27% | -47.64% |
Cash from Operations | 0.00% | 28.97% | 7.47% | 45.98% | 9.04% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | 0.00% | -40.00% | -11.11% | 25.00% | -9.09% |
Issuance of Common Stock | 0.00% | -- | -100.00% | -- | -100.00% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 0.00% | 10,710.00% | -25.00% | -100.00% | -100.08% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 0.00% | 97.01% | 7.32% | -441.21% | -116.51% |